Glycine vs B12 in Compounded Semaglutide: Pros, Cons, and Safety Considerations

Compounded semaglutide formulations frequently include glycine, vitamin B12, or both as additives. For prescribers building semaglutide programs, understanding the specific pros, cons, and safety considerations for each additive in the context of semaglutide (as distinct from tirzepatide) helps you make better prescribing decisions.

Two reasons: clinical and regulatory.

Clinical: Semaglutide therapy is associated with specific side effects and metabolic concerns — nausea, fatigue, and muscle loss — that additives can help address.

Regulatory: Adding a clinically justified ingredient differentiates the compounded preparation from Wegovy or Ozempic, supporting the argument that the preparation is not "essentially a copy" of the branded product.

Both reasons are legitimate, and both should be documented in the patient record.

Glycine is the simplest amino acid and one of the most abundant in the human body. In the context of semaglutide therapy:

Muscle preservation: Semaglutide produces significant weight loss, but approximately 25–40% of the weight lost is lean mass (muscle). Glycine supports muscle protein synthesis and may help shift the weight loss composition toward fat rather than muscle.

Digestive support: Glycine is involved in bile acid conjugation (glycocholic acid, glycochenodeoxycholic acid). Semaglutide slows gastric emptying and can cause GI side effects. Glycine's role in bile acid metabolism may support digestive function during semaglutide therapy.

Anti-inflammatory effects: Glycine inhibits macrophage activation and reduces pro-inflammatory cytokine production. Obesity is characterized by chronic low-grade inflammation; glycine may help reduce this inflammatory burden during weight loss.

Collagen support: Glycine is the most abundant amino acid in collagen (approximately 33% of collagen's amino acid composition). During significant weight loss, skin laxity is a common concern. Glycine supplementation may support collagen synthesis and skin quality.

• Well-tolerated with an excellent safety profile
• Addresses muscle loss — a genuine clinical concern with semaglutide
• Supports digestive function — relevant given semaglutide's GI effects
• Anti-inflammatory properties complement semaglutide's metabolic benefits
• Supports skin quality during weight loss

• Limited clinical trial data specifically in the context of semaglutide
• Does not directly address nausea (the most common patient complaint)
• Requires documentation of clinical rationale for each patient

Glycine has an excellent safety profile. It is a naturally occurring amino acid found in food. At the doses used in compounded formulations (typically 25–100 mg), adverse effects are rare. No significant drug interactions have been identified.

Vitamin B12 (cobalamin) is an essential vitamin involved in neurological function, red blood cell formation, and energy metabolism. In the context of semaglutide therapy:

Fatigue management: Semaglutide-related fatigue is common, particularly during titration. B12 is essential for mitochondrial energy production and may help counteract fatigue.

Nausea support: B12 has some evidence for reducing nausea, though the evidence is less robust than for pyridoxine (B6). Many patients report subjective improvement in nausea with B12 supplementation.

Metformin interaction: Many semaglutide patients are also on metformin for T2D. Metformin reduces B12 absorption by approximately 30%. Co-prescribing B12 directly addresses this interaction.

Neurological support: B12 is essential for myelin synthesis. Patients on calorie-restricted diets during semaglutide therapy may have reduced dietary B12 intake.

• Directly addresses fatigue — the second most common semaglutide complaint after nausea
• Addresses metformin-B12 depletion in T2D patients
• Well-established safety profile
• Available in multiple forms (cyanocobalamin, methylcobalamin) for different patient needs

• Compatibility concerns: Some reports have noted potential stability issues when certain B12 forms are mixed with semaglutide. Always source from compounders who have tested their specific formulation.
• Does not address muscle loss
• Cyanocobalamin requires conversion to active forms — less ideal for patients with MTHFR variants

B12 has an excellent safety profile. It is water-soluble, and excess is excreted in urine. Adverse effects at therapeutic doses are rare. The primary safety consideration is formulation compatibility — ensure your compounding pharmacy has tested the B12/semaglutide combination for stability and compatibility.

For patients with multiple concerns, a hybrid formulation including both B12 and glycine provides comprehensive support. Ensure your compounding pharmacy has tested the complete formulation for stability and compatibility.

Request portal access →

This content is for informational and educational purposes only. It does not constitute medical advice. Prescribers should use clinical judgment when selecting formulations.